A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial-Reference-Cited by-同舟云学术

A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial

Published:2017-07 Issue:7 Volume:7 Page:e015099
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Kotecha Dipak^ORCID,Calvert Melanie^ORCID,Deeks Jonathan J,Griffith Michael,Kirchhof Paulus^ORCID,Lip Gregory YH,Mehta Samir,Slinn Gemma,Stanbury Mary,Steeds Richard P,Townend Jonathan N

Funder

Research Trainees Coordinating Centre

Publisher

BMJ

Subject

General Medicine

Reference87 articles.

1. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur Heart J,2016

2. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study;Chugh;Circulation,2014

3. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060;Krijthe;Eur Heart J,2013

4. Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care;Lane;J Am Heart Assoc,2017

5. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry;Chiang;Circ Arrhythm Electrophysiol,2012

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

2. Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial;Nature Medicine;2024-07

3. Repurposing digoxin for geroprotection in patients with frailty and multimorbidity;Ageing Research Reviews;2023-04

4. Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation;Cardiac Failure Review;2022-11-18

5. Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial;Hellenic Journal of Cardiology;2022-11